Instrument overview

BMYBristol-Myers Squibb

StockNYSEUnited StatesHealth careEU retail: available

+4.6% today · +41.4% over a year

10/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 95% of the instruments we score

Stability: among the best of its peers; priced lower than most peers. Dividend yield 4.25%.

Balanced 10/1010/10Balanced
Weights for long-horizon accumulation: more quality and trend, no dividend requirement. These are three ways to weigh the same factors, not three properties of the instrument; Income compares within the sector, so a low yield can still score high. More in the glossary →10/10
Default weights: value, quality, trend, stability and dividend safety together. These are three ways to weigh the same factors, not three properties of the instrument; Income compares within the sector, so a low yield can still score high. More in the glossary →10/10
Weights for income: dividend safety counts most; shown for dividend payers only. These are three ways to weigh the same factors, not three properties of the instrument; Income compares within the sector, so a low yield can still score high. More in the glossary →9/10

The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.

Compared with: Health care companies in USA (n = 212)

Current rating first published: · last recomputed · rating log

Factor scores

How cheap the company is versus peers: earnings, cash flow, book value and sales relative to its price. More in the glossary →better than 84% of peers
Profitability, balance-sheet safety, growth and capital discipline versus peers. More in the glossary →better than 71% of peers
Price trend over the last 12 and 6 months (excluding the last month) and distance from the 52-week high. More in the glossary →better than 70% of peers
Lower price swings, lower market sensitivity (beta) and shallower drawdowns score higher. More in the glossary →better than 96% of peers
0–100 points: payout versus earnings and cash flow, debt, cut history, growth streak and how stretched the yield looks. More in the glossary →better than 71% of peers

Percentiles within the peer group (100 = the best of its peers); dividend safety in points.

Main drivers

  • Volatility (1 y)supports the score · better than 94% of peers
  • Gross profit growth / assets (5 y)weighs on the score · better than 20% of peers
  • Betasupports the score · better than 95% of peers

Red flags and notes

  • Unverified dividend A high yield reported by a single source only, not yet cross-checked.

Price chart

Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.

Key metrics

Valuation

P/E
13.0
P/B
5.4
P/S
2.5
Free-cash-flow yield
9.4%
Market cap (EUR)
€108B

Profitability and debt

Return on equity
46.7%
Gross margin
70.2%

Dividends

Dividend yield
4.25%
Payout ratio
56%
5-year dividend growth (per year)
5.2%
Years of dividend growth
24

Returns and risk

1 day
+4.6%
1 month
−6.6%
1 year
+41.4%
Volatility, 1 yr
27.5%
Max drawdown, 1 yr
−15.9%
Beta
0.53

Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.

News and filings

  • FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
  • Media reportA headline from a named media outlet. We link to it and do not check it.
  • RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.

Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.

Score changes in the last 12 months

Every published rating and change, logged when it was published (EU Market Abuse Regulation).

DateEventBalancedGrowth · IncomeWarningsPrice at publication
Monthly idea (general research) 10/10 10 · 9 — Available with Invest Pro
First rating 10/10 10 · 9 — Available with Invest Pro

Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.